Two years, two retracted studies.
It is no secret that the American Heart Association is ideologically opposed to vaping. Whether in advocacy or ‘science,’ there is often no line they won’t cross in their quest to confuse and mislead adults about the relative risk of vaping versus cigarette smoking.
In 2020, there was the famous Stanton Glantz heart attack study, which was retracted by the AHA journal thanks to the efforts of researchers like Dr. Brad Rodu and Dr. David Abrams.
Now, AHA has retracted an entire press release about a non-peer-reviewed conference abstract that purported to link vaping to a higher risk of stroke. (archive here)
In covering the ‘study’ prior to its retraction, the Daily Mail at least went to some UK experts to explain why the study should not be taken seriously.
Once the paper had been covered by the press, the AHA belatedly announced that the paper would no longer be presented and deleted the press release.
The lead researchers behind this retracted conference abstract include:
- Urvish K. Patel, M.D., M.P.H., research scholar and chief education officer in the department of public health and neurology at the Icahn School of Medicine at Mount Sinai in New York City
- Neel Patel, M.D., a research scholar in the department of public health at the Icahn School of Medicine at Mount Sinai in New York City.
Dr. Jonathan Foulds, a professor of public health sciences and psychiatry at Penn State University, College of Medicine, also tweeted about the study’s obvious flaws.
